Children of older fathers are more likely to develop schizophrenia in later life

Children of older fathers are more likely to develop schizophrenia in later life, concludes new research published on bmj.com today.

These findings add weight to the theory that accumulating mutations in the sperm of older fathers contributes to the overall risk of schizophrenia.

The study involved over 700,000 people born in Sweden between 1973 and 1980. The analysis was based on records of people admitted to hospital between 1989-2001 with a diagnosis of schizophrenia or other non-affective psychosis.

There was a strong association between increased paternal age at conception and their offspring's risk of schizophrenia, which remained even after taking account of a range of other factors that could have affected the results.

Overall, 15.5% of cases of schizophrenia in this group may have been due to the patient having a father who was aged over 30 years at birth, say the authors.

The association seemed to be relatively specific to schizophrenia compared with non-affective psychosis and was stronger in those with no family history of the disorder. This supports the theory that accumulating mutations in the germ lines of older fathers might contribute to an increased risk of schizophrenia, they add.

In England and Wales the average paternal age has increased from 29.2 years in 1980 to 32.1 in 2002. Based on their data, the authors estimate that this increase could have led to an additional 710 cases of schizophrenia in 2002 over and above the 5,923 cases due to the background incidence rate.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New protein platform enhances cancer immunotherapy